Literature DB >> 4082361

Clostridium difficile induced colitis occurring during cefotaxime therapy.

S T Green, R Mackie, H McMillan, J W Davie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4082361      PMCID： PMC2448003     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  7 in total

1.  Clinical experience in the diagnosis and treatment of infections in the compromised host.

Authors:  L A Cone; D Woodard; N A Helm
Journal:  Clin Ther       Date:  1981       Impact factor: 3.393

2.  [Pseudomembranous rectocolitis after treatment by cefotaxime].

Authors:  J L Gineston; X Henry
Journal:  Nouv Presse Med       Date:  1982-05-29

3.  HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity.

Authors:  Y A Chabbert; A J Lutz
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

4.  Undescribed toxin in pseudomembranous colitis.

Authors:  H E Larson; J V Parry; A B Price; D R Davies; J Dolby; D A Tyrrell
Journal:  Br Med J       Date:  1977-05-14

5.  Cefotaxime therapy for patients with osteomyelitis and septic arthritis.

Authors:  J T Mader; J L LeFrock; K C Hyams; A Molavi; J A Reinarz
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

6.  Clinical efficacy of cefotaxime in serious infections.

Authors:  P H Karakusis; J M Feczko; L J Goodman; D M Hanlon; A A Harris; S Levin; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

7.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321
  7 in total
  1 in total

1.  Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

Authors:  M Impallomeni; N P Galletly; S J Wort; J M Starr; T R Rogers
Journal:  BMJ       Date:  1995-11-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.